BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32977748)

  • 1. Cohort profile: King's Health Partners bladder cancer biobank.
    Kotecha P; Moss CL; Enting D; Gillett C; Joseph M; Josephs D; Rudman S; Hughes S; Cahill F; Wylie H; Haire A; Rosekilly J; Khan MS; Nair R; Thurairaja R; Malde S; Van Hemelrijck M
    BMC Cancer; 2020 Sep; 20(1):920. PubMed ID: 32977748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. King's Health Partners' Prostate Cancer Biobank (KHP PCaBB).
    Saifuddin SR; Devlies W; Santaolalla A; Cahill F; George G; Enting D; Rudman S; Cathcart P; Challacombe B; Dasgupta P; Galustian C; Chandra A; Chowdhury S; Gillett C; Van Hemelrijck M
    BMC Cancer; 2017 Nov; 17(1):784. PubMed ID: 29166865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Infectious Diseases BioBank at King's College London: archiving samples from patients infected with HIV to facilitate translational research.
    Williams R; Mant C; Cason J
    Retrovirology; 2009 Nov; 6():98. PubMed ID: 19886990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morocco's First Biobank: Establishment, Ethical Issues, Biomedical Research Opportunities, and Challenges.
    Lhousni S; Belmokhtar KY; Belmokhtar I; Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Tajir M; Charif M; Zerrouki K; Benajiba N; Rkain M; Babakhouya A; Kouismi H; Thouil A; Latrach H; Amrani R; Messaoudi S; Ayyad A; Sidqi Z; Andaloussi Serraj K; Hamaz S; Alaoui H; Bachir H; Bentata Y; Haddiya I; Choukri M; Seddik R; Bennani A; Dikhaye S; Oneib B; Elghazouani F; El Mahi O; Benzirar A; Oufkir AA; Housni B; Mimouni A; Saadi H; Belahcen M; El Harroudi T; Ouarzane M; Bellaoui M
    Biomed Res Int; 2020; 2020():8812609. PubMed ID: 33376744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project.
    De Gregorio A; Nagel G; Möller P; Rempen A; Schlicht E; Fritz S; Flock F; Kühn T; Thiel F; Felberbaum R; Ebner F; De Gregorio N; Friedl TWP; Wiesmüller L; Kuhn P; Schmitt M; Janni W; Rothenbacher D; Huober J
    Arch Gynecol Obstet; 2020 Jan; 301(1):273-281. PubMed ID: 31781887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UK Biobank sample handling and storage validation studies.
    Peakman TC; Elliott P
    Int J Epidemiol; 2008 Apr; 37 Suppl 1():i2-6. PubMed ID: 18381389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The establishment of an ISO compliant cancer biobank for Jordan and its neighboring countries through knowledge transfer and training.
    Barr MP; Souan L; MacGabhann P; Müller J; Al Ashhab M; Jasser M; Hamza K; Al Hassoon S; Kuhn U; Infante D; Lawlor D; Gately K; Amireh E; O'Byrne K; Sughayer MA
    Biopreserv Biobank; 2014 Feb; 12(1):3-12. PubMed ID: 24620764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics, lifestyle and environment. UK Biobank is an open access resource following the lives of 500,000 participants to improve the health of future generations.
    Trehearne A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):361-7. PubMed ID: 26753864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years.
    Rønningen KS; Paltiel L; Meltzer HM; Nordhagen R; Lie KK; Hovengen R; Haugen M; Nystad W; Magnus P; Hoppin JA
    Eur J Epidemiol; 2006; 21(8):619-25. PubMed ID: 17031521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The moral concerns of biobank donors: the effect of non-welfare interests on willingness to donate.
    De Vries RG; Tomlinson T; Kim HM; Krenz CD; Ryan KA; Lehpamer N; Kim SY
    Life Sci Soc Policy; 2016; 12():3. PubMed ID: 26968989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective associations between depression and risk of hospitalisation for infection: Findings from the UK Biobank.
    Ronaldson A; Arias de la Torre J; Sima R; Ashworth M; Armstrong D; Bakolis I; Hotopf M; Dregan A
    Brain Behav Immun; 2022 May; 102():292-298. PubMed ID: 35218891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice - from biobank to RNA-sequencing in real time.
    Liedberg F; Abrahamsson J; Bernardo C; Bläckberg M; Edsjö A; Heidenblad M; Larsson C; Sjödahl G; Eriksson P
    Scand J Urol; 2023; 57(1-6):2-9. PubMed ID: 36540001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Report from the 9th symposium of the German Association for Bladder Cancer Research].
    Schulz WA; Hoffmann MJ; Niegisch G; Füssel S; Nawroth R
    Urologe A; 2020 Jun; 59(6):731-732. PubMed ID: 32242269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality Control System in an Obstetrics and Gynecology Disease Biobank.
    Liu Y; Gao H; Hu Y; Ding J; Ge M; Ye Q
    Biopreserv Biobank; 2019; 17(1):27-38. PubMed ID: 30299984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
    Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
    Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research.
    Zelisse HS; van Gent MDJM; de Ridder S; van der Aa MA; van Altena AM; Bart J; Belien JAM; Boere IA; Bosch SL; Broeks A; Bulten J; Collée M; Groenendijk FH; Horlings HM; Jansen MPHM; Jonges TGN; Kooreman LFS; de Kroon CD; Lambrechts S; Lok CAR; Piek JM; Reyners AKL; Roes EM; Simons M; Wisman GBA; Yigit R; Zweemer RP; Mom CH; van de Vijver MJ; Dijk F;
    Gynecol Obstet Invest; 2022; 87(6):389-397. PubMed ID: 36450222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
    Piao XM; Jeong P; Kim YH; Byun YJ; Xu Y; Kang HW; Ha YS; Kim WT; Lee JY; Woo SH; Kwon TG; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
    Int J Cancer; 2019 Jan; 144(2):380-388. PubMed ID: 30183088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biobank Establishment and Sample Management in the Tohoku Medical Megabank Project.
    Minegishi N; Nishijima I; Nobukuni T; Kudo H; Ishida N; Terakawa T; Kumada K; Yamashita R; Katsuoka F; Ogishima S; Suzuki K; Sasaki M; Satoh M; Tohoku Medical Megabank Project Study Group ; Yamamoto M
    Tohoku J Exp Med; 2019 May; 248(1):45-55. PubMed ID: 31130587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
    Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer.
    Wang Z; Li H; Chi Q; Qiu Y; Li X; Xin L
    Med Sci Monit; 2018 Jun; 24():3882-3887. PubMed ID: 29883442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.